{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:56:42Z","timestamp":1777373802784,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10735-026-10730-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:12:57Z","timestamp":1773763977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of targeted regulation of miR-499a-5p\/integrin \u03b21 by circ_001567 on malignant progression of gastric cancer cells"],"prefix":"10.1007","volume":"57","author":[{"given":"Xixi","family":"Mu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"2","key":"10730_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/cbr.2018.2641","volume":"34","author":"LP Bao","year":"2019","unstructured":"Bao LP, Zhong JX, Pang LJ (2019) Upregulation of circular RNA VPS13C-has-circ-001567 promotes ovarian cancer cell proliferation and invasion. Cancer Biother Radiopharm 34(2):110\u2013118. https:\/\/doi.org\/10.1089\/cbr.2018.2641","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"10730_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"10730_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143404","volume":"14","author":"G Cammarata","year":"2022","unstructured":"Cammarata G, Barraco N, Giusti I et al (2022) Extracellular vesicles-ceRNAs as ovarian cancer biomarkers: looking into circRNA-miRNA-mRNA code. Cancers (Basel) 14(14):3404. https:\/\/doi.org\/10.3390\/cancers14143404","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10730_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"DL Chen","year":"2021","unstructured":"Chen DL, Sheng H, Zhang DS et al (2021) The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer 20(1):166. https:\/\/doi.org\/10.1186\/s12943-021-01475-8","journal-title":"Mol Cancer"},{"issue":"1","key":"10730_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04304-2","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Wu Z, Deng W, Tang M, Wu L, Lin N, Chen L, Fu Y, Zhao M, Chen C, Li W (2023a) USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1. J Transl Med 21(1):453. https:\/\/doi.org\/10.1186\/s12967-023-04304-2","journal-title":"J Transl Med"},{"issue":"1","key":"10730_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03147-7","volume":"23","author":"D Chen","year":"2023","unstructured":"Chen D, Li Q, Xu Y et al (2023b) Leveraging a disulfidptosis-related lncRNAs signature for predicting the prognosis and immunotherapy of glioma. Cancer Cell Int 23(1):316. https:\/\/doi.org\/10.1186\/s12935-023-03147-7","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10730_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3164\/jcbn.22-130","volume":"73","author":"D Fan","year":"2023","unstructured":"Fan D, Ma Y, Qi Y et al (2023) TMEM189 as a target gene of MiR-499a-5p regulates breast cancer progression through the ferroptosis pathway. J Clin Biochem Nutr 73(2):154\u2013160. https:\/\/doi.org\/10.3164\/jcbn.22-130","journal-title":"J Clin Biochem Nutr"},{"issue":"8","key":"10730_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.7655\/NYDXBNS20200811","volume":"40","author":"QC Feng","year":"2020","unstructured":"Feng QC, Zou X, Wang GR et al (2020) A predictive model of circRNA-miRNA regulation in thyroid carcinoma based on integrated microarray analysis. J Nanjing Med Univ (Nat Sci) 40(8):1140\u20131148. https:\/\/doi.org\/10.7655\/NYDXBNS20200811","journal-title":"J Nanjing Med Univ (Nat Sci)"},{"issue":"12","key":"10730_CR9","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/ijbs.58916","volume":"17","author":"B Fu","year":"2021","unstructured":"Fu B, Liu W, Zhu C et al (2021) Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis. Int J Biol Sci 17(12):3104\u20133117. https:\/\/doi.org\/10.7150\/ijbs.58916","journal-title":"Int J Biol Sci"},{"key":"10730_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.945310","volume":"13","author":"M Gao","year":"2022","unstructured":"Gao M, Zhang Z, Sun J et al (2022) The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis. Front Endocrinol (Lausanne) 13:945310. https:\/\/doi.org\/10.3389\/fendo.2022.945310","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10730_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2023.12.003","volume":"282","author":"T Gonzalez","year":"2024","unstructured":"Gonzalez T, Nie Q, Chaudhary LN et al (2024) Methylation signatures as biomarkers for non-invasive early detection of breast cancer: a systematic review of the literature. Cancer Genet 282:1\u20138. https:\/\/doi.org\/10.1016\/j.cancergen.2023.12.003","journal-title":"Cancer Genet"},{"issue":"1","key":"10730_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH (2023) Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10730_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04388-2","volume":"24","author":"S Guo","year":"2024","unstructured":"Guo S, Huang B, You Z et al (2024) FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378\u00a0g\/CRABP2 axis. BMC Oral Health 24(1):625. https:\/\/doi.org\/10.1186\/s12903-024-04388-2","journal-title":"BMC Oral Health"},{"issue":"18","key":"10730_CR14","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3969\/j.issn.1005-9202.2023.18.061","volume":"43","author":"XR Han","year":"2023","unstructured":"Han XR, Yang L, Yao SX (2023) Circ_BIRC6 targets miR-363-3p to regulate the proliferation, migration and apoptosis of gastric cancer cells. Chin J Gerontol 43(18):4581\u20134585. https:\/\/doi.org\/10.3969\/j.issn.1005-9202.2023.18.061","journal-title":"Chin J Gerontol"},{"key":"10730_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107402","volume":"165","author":"J Huang","year":"2023","unstructured":"Huang J, Zhang J, Zhang F et al (2023) Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Comput Biol Med 165:107402. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107402","journal-title":"Comput Biol Med"},{"key":"10730_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288-289","author":"L Jahangiri","year":"2024","unstructured":"Jahangiri L (2024) Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet 288\u2013289:32\u201339. https:\/\/doi.org\/10.1016\/j.cancergen.2024.09.001","journal-title":"Cancer Genet"},{"issue":"2","key":"10730_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2530","volume":"34","author":"MJ Kamali","year":"2024","unstructured":"Kamali MJ, Salehi M, Mostafavi M et al (2024) Hijacking and rewiring of host circRNA\/miRNA\/mRNA competitive endogenous RNA (ceRNA) regulatory networks by oncoviruses during development of viral cancers. Rev Med Virol 34(2):e2530. https:\/\/doi.org\/10.1002\/rmv.2530","journal-title":"Rev Med Virol"},{"issue":"2","key":"10730_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, Jiang S, Han JX et al (2024) Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta (BBA) Mol Basis Dis 1870(2):166941. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166941","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"6","key":"10730_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"SJ Lee","year":"2024","unstructured":"Lee SJ, Jeon SH, Cho S et al (2024) hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells. Biochim Biophys Acta Mol Basis Dis 1870(6):167250. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167250","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10730_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.214160","volume":"169","author":"M Lee","year":"2025","unstructured":"Lee M, Hwang J, Song Y et al (2025) Anti-miR21-conjugated DNA nanohydrogel for enhanced cancer therapy. Biomater Adv 169:214160. https:\/\/doi.org\/10.1016\/j.bioadv.2024.214160","journal-title":"Biomater Adv"},{"issue":"3","key":"10730_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.13602\/j.cnki.jcls.2021.03.12","volume":"39","author":"S Li","year":"2021","unstructured":"Li S, Wang MY, Zang XY et al (2021a) Research progress of CircRNA in gastric cancer. Chin J Clin Lab Sci 39(3):213\u2013217. https:\/\/doi.org\/10.13602\/j.cnki.jcls.2021.03.12","journal-title":"Chin J Clin Lab Sci"},{"issue":"2","key":"10730_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7150\/ijbs.52319","volume":"17","author":"YX Li","year":"2021","unstructured":"Li YX, Sun C, Tan YG et al (2021b) ITGB1 enhances the radioresistance of human non-small cell lung cancer cells by modulating the DNA damage response and YAP1-induced epithelial-mesenchymal transition. Int J Biol Sci 17(2):635\u2013650. https:\/\/doi.org\/10.7150\/ijbs.52319","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10730_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cac2.12460","volume":"43","author":"JJ Li","year":"2023","unstructured":"Li JJ, Xiao XC, Ou Y et al (2023) USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer. Cancer Commun 43(7):765\u2013787. https:\/\/doi.org\/10.1002\/cac2.12460","journal-title":"Cancer Commun"},{"issue":"1","key":"10730_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C, Zhou Y (2021a) N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 20(1):105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4","journal-title":"Mol Cancer"},{"issue":"2","key":"10730_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020234","volume":"13","author":"H Liu","year":"2021","unstructured":"Liu H, Dilger JP, Lin J (2021b) Lidocaine suppresses viability and migration of human breast cancer cells: TRPM7 as a target for some breast cancer cell lines. Cancers (Basel) 13(2):234. https:\/\/doi.org\/10.3390\/cancers13020234","journal-title":"Cancers (Basel)"},{"key":"10730_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2024.05.002","volume":"286-287","author":"D Liu","year":"2024","unstructured":"Liu D, Shen M, Liu Z et al (2024) SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1. Cancer Genet 286\u2013287:1\u201310. https:\/\/doi.org\/10.1016\/j.cancergen.2024.05.002","journal-title":"Cancer Genet"},{"issue":"12","key":"10730_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13121713","volume":"13","author":"E Mehmetbeyoglu","year":"2023","unstructured":"Mehmetbeyoglu E, Duman A, Taheri S et al (2023) From data to insights: machine learning empowers prognostic biomarker prediction in autism. J Pers Med 13(12):1713. https:\/\/doi.org\/10.3390\/jpm13121713","journal-title":"J Pers Med"},{"key":"10730_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cancergen.2023.12.002","volume":"280","author":"H Ohyama","year":"2024","unstructured":"Ohyama H, Hirotsu Y, Amemiya K et al (2024) Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing. Cancer Genet 280:6\u201312. https:\/\/doi.org\/10.1016\/j.cancergen.2023.12.002","journal-title":"Cancer Genet"},{"issue":"24","key":"10730_CR29","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-6556","volume":"9","author":"L Ouyang","year":"2021","unstructured":"Ouyang L, Liu RD, Lei DQ et al (2021) MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K\/Akt signaling by targeting PTEN in pancreatic cancer. Ann Transl Med 9(24):1798. https:\/\/doi.org\/10.21037\/atm-21-6556","journal-title":"Ann Transl Med"},{"key":"10730_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113207","volume":"142","author":"B Seok Han","year":"2024","unstructured":"Seok Han B, Ko S, Seok Park M et al (2024) Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-\u03b2\/Smad-mediated EMT signaling by reprogramming tumor-associated macrophages. Int Immunopharmacol 142:113207. https:\/\/doi.org\/10.1016\/j.intimp.2024.113207","journal-title":"Int Immunopharmacol"},{"issue":"21","key":"10730_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37089","volume":"10","author":"M Shahpari","year":"2024","unstructured":"Shahpari M, Hashemi M, Younesirad T et al (2024) The functional roles of competitive endogenous RNA (ceRNA) networks in apoptosis in human cancers: the circRNA\/miRNA\/mRNA regulatory axis and cell signaling pathways. Heliyon 10(21):e37089. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37089","journal-title":"Heliyon"},{"issue":"5","key":"10730_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24369","volume":"36","author":"YF Shao","year":"2022","unstructured":"Shao YF, Qi CL, Yan JN et al (2022) Biological and clinical implications of hsa_circ_0086720 in gastric cancer and its clinical application. J Clin Lab Anal 36(5):e24369. https:\/\/doi.org\/10.1002\/jcla.24369","journal-title":"J Clin Lab Anal"},{"issue":"42","key":"10730_CR33","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/s41388-022-02449-w","volume":"41","author":"XJ Shen","year":"2022","unstructured":"Shen XJ, Kong S, Ma S et al (2022) Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis. Oncogene 41(42):4724\u20134735. https:\/\/doi.org\/10.1038\/s41388-022-02449-w","journal-title":"Oncogene"},{"issue":"1","key":"10730_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1515\/med-2021-0355","volume":"17","author":"WT Shi","year":"2022","unstructured":"Shi WT, Wang F (2022) circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer. Open Med 17(1):280\u2013291. https:\/\/doi.org\/10.1515\/med-2021-0355","journal-title":"Open Med"},{"issue":"4","key":"10730_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115431","volume":"44","author":"K Sobkowiak","year":"2025","unstructured":"Sobkowiak K, Kohzaki M, B\u00f6hm R et al (2025) REV7 functions with REV3 as a checkpoint protein delaying mitotic entry until DNA replication is completed. Cell Rep 44(4):115431. https:\/\/doi.org\/10.1016\/j.celrep.2025.115431","journal-title":"Cell Rep"},{"issue":"2","key":"10730_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14670\/HH-18-508","volume":"38","author":"SQ Tan","year":"2023","unstructured":"Tan SQ, Hu LB, Lei R et al (2023) Circ_0000467 regulates proliferation, migration, invasion, and apoptosis in gastric cancer by targeting the miR-622\/ROCK2 axis. Histol Histopathol 38(2):185\u2013197. https:\/\/doi.org\/10.14670\/HH-18-508","journal-title":"Histol Histopathol"},{"issue":"1","key":"10730_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M et al (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 15(1):174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10730_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10565-022-09762-w","volume":"39","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jiang RK, Zhao HY et al (2023) TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies. Cell Biol Toxicol 39(2):557\u2013571. https:\/\/doi.org\/10.1007\/s10565-022-09762-w","journal-title":"Cell Biol Toxicol"},{"issue":"9","key":"10730_CR39","first-page":"6445","volume":"14","author":"J Wu","year":"2022","unstructured":"Wu J, Wang W, Li Z, Ye X (2022) The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer. Am J Transl Res. 14(9):6445\u20136466","journal-title":"Am J Transl Res."},{"issue":"1","key":"10730_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02930-0","volume":"23","author":"C Xu","year":"2023","unstructured":"Xu C, Xie XL, Kang N et al (2023) Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer. BMC Gastroenterol 23(1):298. https:\/\/doi.org\/10.1186\/s12876-023-02930-0","journal-title":"BMC Gastroenterol"},{"key":"10730_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820957001","volume":"19","author":"L Zhao","year":"2020","unstructured":"Zhao L, Jiang P, Zheng H et al (2020a) Downregulation of miR-499a-5p predicts a poor prognosis of patients with non-small cell lung cancer and restrains the tumorigenesis by targeting fibroblast growth factor 9. Technol Cancer Res Treat 19:1533033820957001. https:\/\/doi.org\/10.1177\/1533033820957001","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10730_CR42","doi-asserted-by":"publisher","first-page":"153303382095700","DOI":"10.1177\/1533033820957001","volume":"19","author":"LH Zhao","year":"2020","unstructured":"Zhao LH, Jiang P, Zheng H et al (2020b) Downregulation of miR-499a-5p predicts a poor prognosis of patients with non-small cell lung cancer and restrains the tumorigenesis by targeting fibroblast growth factor 9. Technol Cancer Res Treat 19(1):1533033820957001. https:\/\/doi.org\/10.1177\/1533033820957001","journal-title":"Technol Cancer Res Treat"},{"key":"10730_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930278","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Guo S, Schrodi SJ et al (2022) Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: implication, prospects, and perspectives. Front Immunol 13:930278. https:\/\/doi.org\/10.3389\/fimmu.2022.930278","journal-title":"Front Immunol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10730-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10730-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:56:55Z","timestamp":1777366615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10730-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10730"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10730-5","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the Declaration of Helsinki. Human sample collection was approved by the Ethical Committee of Xi'an Central Hospital. Informed consent was obtained from all participating patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}],"article-number":"114"}}